Ghost Tree Capital, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Ghost Tree Capital, LLC
- $310 Million
- Q1 2024
A detailed history of Ghost Tree Capital, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 90,000 shares of EYPT stock, worth $782,999. This represents 0.6% of its overall portfolio holdings.
Number of Shares
90,000
Previous 165,000
45.45%
Holding current value
$782,999
Previous $3.81 Million
51.22%
% of portfolio
0.6%
Previous 1.38%
Shares
3 transactions
Others Institutions Holding EYPT
# of Institutions
176Shares Held
53.9MCall Options Held
764KPut Options Held
1.57M-
Cormorant Asset Management, LP Boston, MA6.89MShares$60 Million8.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.76MShares$41.4 Million0.19% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.76MShares$32.7 Million3.33% of portfolio
-
Franklin Resources Inc San Mateo, CA3.39MShares$29.5 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$24.3 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $296M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...